Patents Assigned to West Affum Holdings DAC
-
Publication number: 20240157162Abstract: Embodiments of a wearable cardioverter defibrillator (WCD) system include a support structure for wearing by an ambulatory patient and at least one processor. When worn, the support structure maintains electrodes on the patient's body, and using the patient's ECG received via the electrodes, the processor determines widths of the QRS complexes, consistency of the QRS complexes, and/or heart rate and uses these determinations to make no-shock, delay-shock, and shock decisions. Shock decisions can be made for heart rates lower than a VF threshold.Type: ApplicationFiled: January 5, 2024Publication date: May 16, 2024Applicant: West Affum Holdings DACInventor: Joseph L. Sullivan
-
Patent number: 11984677Abstract: Technologies and implementations for a clip to connect coaxial cables onto a printed circuit board assembly (PCBA) are disclosed. The technologies and implementations facilitate improved signal integrity from the cable to various components of the PCBA. Additionally, the technologies and implementations help facilitate management of mechanical variations during connection of the coaxial cable.Type: GrantFiled: July 12, 2021Date of Patent: May 14, 2024Assignee: WEST AFFUM HOLDINGS DACInventors: Robert R. Buchanan, Douglas K. Medema, Daniel R. Piha, Dallas E. Meeker, Daniel J. Finney
-
Patent number: 11975185Abstract: A wearable cardioverter defibrillator (“WCD”) system may include an impedance detector configured to render an impedance signal of the patient. The WCD system may determine, from the impedance signal, a characteristic of breathing by the patient that can be used as a vital sign. The WCD system may determine, from at least the breathing characteristic, whether or not a shock criterion is met. If the shock criterion is met, the WCD system may control a discharge circuit to discharge a stored electrical charge through the patient. An advantage can be that the breathing characteristic may be used to determine whether or not a patient is experiencing a condition that requires defibrillation therapy, such as sudden cardiac arrest. Even more advantages can be had in discerning the state of the patient when the breathing characteristic is combined with other data, such as from a motion detector.Type: GrantFiled: June 30, 2021Date of Patent: May 7, 2024Assignee: West Affum Holdings DACInventors: Laura M. Gustavson, Kenneth Frederick Cowan
-
Patent number: 11974855Abstract: In one embodiment, a method to detect noise levels in electrocardiogram (ECG) signals. The method includes connecting to at least three sensing electrodes and obtaining a signal from each of the at least three sensing electrodes. The method also includes defining at least three channels between the at least three electrodes and obtaining heart data for a predetermined time period from the at least three channels wherein the heart data includes heart rate and QRS width. The method further includes comparing the heart data of each of the at least three channels to a consistency threshold.Type: GrantFiled: April 2, 2021Date of Patent: May 7, 2024Assignee: WEST AFFUM HOLDINGS DACInventors: Jaeho Kim, Joseph L. Sullivan
-
Publication number: 20240139524Abstract: A data file system includes one or more files about a patient wearing a wearable cardiac defibrillator (WCD) system that has been assigned to them. The one or more files contain at least one patient identifier of the patient, compliance data about a history of the patient's wearing the WCD system, and possibly other data. The data file system can be accessed through a communication network when the patient uses a communication device. When so accessed, some of the contents can be viewed on a screen of the device, for example in the form of a website.Type: ApplicationFiled: December 28, 2023Publication date: May 2, 2024Applicant: West Affum Holdings DACInventors: Laura Marie Gustavson, David Peter Finch, Erick Michael Roane, Jason Fouts
-
Publication number: 20240139531Abstract: Apparatus and methods for generating pulse pacing in a wearable cardioverter defibrillator (“WCD”). In one aspect the WCD circuitry includes a power source such as a battery coupled to a charger that provides charge energy to an energy storage module. Control circuitry is operatively coupled to the charger and the output circuitry, and configured to cause the WCD circuitry to generate pacing pulses delivered to therapy electrodes (attached to an ambulatory patient) without a current source. The WCD circuitry includes one or more processing elements that are used to execute instructions provided by one or more software modules that are configured to support various functionality, including controlling generation of pacing pulses.Type: ApplicationFiled: August 8, 2023Publication date: May 2, 2024Applicant: West Affum Holdings DACInventors: David P. Finch, Leo J. Gilbert, Joseph L. Sullivan, Jaeho Kim, John Wei-Hao Huang, Brian J. Bennett, Kenneth F. Cowan
-
Publication number: 20240139530Abstract: A WCD system is configured to monitor various characteristics of the WCD system including about the patient. The information collected by the WCD is generally referred to as “patient information.” The WCD system is further configured to transmit certain of the patient information to different recipients based on predetermined profiles with which one or more of the recipients is associated. In various embodiments, different sets or subsets of the patient information may be sent to different recipients.Type: ApplicationFiled: January 11, 2024Publication date: May 2, 2024Applicant: West Affum Holdings DACInventors: Steven E. Sjoquist, Jonathan P. Niegowski, Zoie R. Engman, Pamela F. Breske
-
Patent number: 11969607Abstract: A Wearable Cardioverter Defibrillator (WCD) system has a processor that performs two different analyses to an ECG of the patient. A first-level analysis can be computationally economical, while a fuller second-level analysis can give shock/no-shock advice with more certainty. In some of these embodiments the second-level analysis of the ECG is performed only if the first-level analysis of the ECG detects a possible shockable condition. As such, the first-level analysis may operate as a gatekeeping function, often preventing the more computationally intensive second-level analysis from being performed. An advantage can be that the WCD system needs to store less charge, for powering the processor. In turn, this permits portions of the WCD system to be less bulky and weigh less.Type: GrantFiled: March 8, 2021Date of Patent: April 30, 2024Assignee: West Affum Holdings DACInventors: Joseph L. Sullivan, Jaeho Kim
-
Publication number: 20240131349Abstract: In embodiments, a wearable cardioverter defibrillator (WCD) system includes electrodes that render an ECG signal of the patient, and a processor that receives ECG data are derived from the rendered ECG signal. The processor may filter the received ECG data with a matched difference filter to detect QRS complexes, and compute a heart rate from the detected QRS complexes. The matched difference filter itself can have coefficient values associated with a baseline QRS complex, which improves detection.Type: ApplicationFiled: December 20, 2023Publication date: April 25, 2024Applicant: West Affum Holdings DACInventor: Joseph L. Sullivan
-
Publication number: 20240122518Abstract: A wearable cardioverter defibrillator (WCD) including a support structure configured to be worn by an ambulatory patient, an energy storage module configured to store an electrical charge, a discharge circuit coupled to the energy storage module, electrodes configured to render an electrocardiogram (ECG) signal of the patient while the patient is wearing the support structure, a user interface configured to output an alarm in response to a noise alarm signal, and a processor. The processor is configured to receive the ECG signal, determine whether noise is present on the ECG signal, determine from the ECG signal whether a shock criterion is met, and cause the user interface to generate the noise alarm signal when the noise is present on the ECG signal and the shock criterion is met and not generate the noise alarm signal when noise is present on the ECG signal and the shock criterion is not met.Type: ApplicationFiled: December 27, 2023Publication date: April 18, 2024Applicant: West Affum Holdings DACInventors: Joseph L. Sullivan, Jaeho Kim
-
Publication number: 20240119380Abstract: Embodiments of this disclosure are directed to a wearable cardioverter defibrillator (“WCD”) system design in which a WCD implements an alert prioritization scheme to provide the patient with feedback in an order that is less likely to cause confusion. Different conditions (e.g., device status, equipment condition, or physiologic condition) are prioritized based on an analysis of severity of the condition and timeliness of user action needed. The prioritization scheme defines what alert, if any, is presented to the user by the WCD system as a result of various conditions. Generally stated, an alert for the highest priority condition currently detected is presented to the user and maintained until that condition either changes or becomes surpassed in the prioritization scheme.Type: ApplicationFiled: December 15, 2023Publication date: April 11, 2024Applicant: West Affum Holdings DACInventors: Zoie R. Engman, Pamela F. Breske, David P. Finch, Erick M. Roane
-
Patent number: 11951321Abstract: A conductive fluid reservoir can be used to dispense conductive fluid to increase electrical connectivity between an electrode of a defibrillator and a patient. The reservoir includes a container that holds the conductive fluid, one or more outlets on the container, and an inflatable pouch located at least partially within the container. The inflatable pouch is capable of being inflated from a deflated state to an inflated state. In the deflated state, a free end of the inflatable pouch covers the one or more outlets. In the inflated state, the free end of the inflatable pouch is removed from the one or more outlets such that the conductive fluid is allowed to flow out of the container via the one or more outlets. Inflating the inflatable pouch causes the conductive fluid to be dispensed from the reservoir.Type: GrantFiled: February 15, 2021Date of Patent: April 9, 2024Assignee: West Affum Holdings DACInventor: Dallas Meeker
-
Patent number: 11950174Abstract: In one embodiment, a method of alerting a user of a WCD is described. The method includes receiving an alert from the WCD on a remote device associated with the user and in communication with the WCD and transcribing the alert into a message for the user. The method also includes personalizing the message for the user and delivering the message to the user via the remote device.Type: GrantFiled: May 17, 2021Date of Patent: April 2, 2024Assignee: WEST AFFUM HOLDINGS DACInventors: Laura M. Gustavson, David P. Finch, Steven E. Sjoquist, Heather Mareth, Erik L. Schneider, Zoie R. Engman
-
Patent number: 11944835Abstract: In embodiments, a Wearable Cardioverter Defibrillator (WCD) system includes a support structure for the patient to wear, and components that the support structure maintains on the patient's body. The components include a defibrillator, associated electrodes, and so on. The defibrillator can operate in a WCD mode while the patient wears the support structure. The defibrillator can further operate in a different, AED mode, during which time the patient need not wear a portion of the support structure, or even the entire support structure. Sometimes the AED mode is a type of a fully automatic AED mode. Other times the AED mode is a type of a semi-automated AED mode, where an attendant is present to administer the shock; at such times, the patient may not even need to have electrodes attached. This way the patient is more comfortable for a longer time.Type: GrantFiled: July 16, 2021Date of Patent: April 2, 2024Assignee: West Affum Holdings DACInventors: Brian D. Webster, Zoie R. Engman, Phillip D. Foshee, Jr., David P. Finch, Joseph L Sullivan, Gregory T. Kavounas
-
Publication number: 20240099658Abstract: The disclosure is directed at an accessory for a garment that may be worn in conjunction with a wearable medical device (WMD). Certain embodiments of the accessory enable customization of the garment for disparate physical anatomies of various patients. Other embodiments of the accessory enable customization of the garment for aesthetics and comfort of various patients. Non-exhaustive examples of such a WMD include wearable cardioverter defibrillators and wearable monitoring devices.Type: ApplicationFiled: September 26, 2023Publication date: March 28, 2024Applicant: WEST AFFUM HOLDINGS DACInventors: Pamela F. Breske, Alexis Cummings, Kimberly L. Malone, Christina K. House, Jennifer D. Imerini, Traci S. Umberger, Brian D. Webster, Krystyna Szul
-
Patent number: 11938334Abstract: In embodiments, a wearable cardioverter defibrillator (WCD) system includes a support structure for wearing by an ambulatory patient. When worn, the support structure maintains electrodes on the patient's body. Different pairs of these electrodes define different channels, and different patient ECG signals can be sensed from the channels. The ECG signals can be analyzed to determine which one is the best to use, for the WCD system to make a shock/no shock decision. The analysis can be according to widths of the QRS complexes, consistency of the QRS complexes, or heart rate agreement statistics.Type: GrantFiled: October 5, 2022Date of Patent: March 26, 2024Assignee: West Affum Holdings DACInventor: Joseph L. Sullivan
-
Patent number: 11938333Abstract: A wearable medical includes a walking detector module with a motion sensor that is configured to detect when the patient is walking or running. In embodiments, a parameter (referred to herein as a “Bouncy” parameter) is determined from Y-axis acceleration measurements. In some embodiments, the Bouncy parameter is a measurement of the AC component of the Y-axis accelerometer signal. This detection can be used by the medical device to determine how and/or whether to provide treatment to the patient wearing the medical device. For example, when used in a WCD, the walking detector can prevent “false alarms” because a walking patient is generally conscious and not in need of a shock.Type: GrantFiled: July 29, 2022Date of Patent: March 26, 2024Assignee: West Affum Holdings DACInventors: Jaeho Kim, Joseph L Sullivan, Robert P. Marx
-
Patent number: 11931591Abstract: Disclosed are embodiments directed to security methods applied to connections between components in a distributed (networked) system including medical and non-medical devices, providing secure authentication, authorization, patient and device data transfer, and patient data association and privacy for components of the system.Type: GrantFiled: May 6, 2022Date of Patent: March 19, 2024Assignee: West Affum Holdings DACInventors: Steven E. Sjoquist, David P. Finch, Erick M. Roane, Zoie R. Engman, Jonathan P. Niegowski, Dusan Beblavy, Martin Pribula, Peter Curila, Martin Kolesár
-
Publication number: 20240075307Abstract: A wearable cardioverter defibrillator monitor case includes a housing configured to surround a defibrillator electronics assembly, a front cover removably attachable to the housing, and a rear cover removably attachable to the housing. The wearable cardioverter defibrillator case has a shock indicator positioned on the housing at an interface between the housing and the front cover.Type: ApplicationFiled: November 6, 2023Publication date: March 7, 2024Applicant: West Affum Holdings DACInventors: Robert R. Buchanan, Quan H. Nguyen, Allison Staheli, Larry J. Spyridis, Rachel G. Taylor
-
Publication number: 20240058596Abstract: Embodiments of a wearable cardioverter defibrillator (WCD) system include a support structure for wearing by an ambulatory patient, a posture detector and at least one processor. When worn, the support structure maintains electrodes on the patient's body, and using the posture detector and the patient's ECG received via the electrodes, the processor determines the patient's posture, formulates posture-based templates of QRS complexes, and the patient's heart rate. The processor can use these determinations to distinguish between VT and SVT and make no-shock, and shock decisions.Type: ApplicationFiled: October 31, 2023Publication date: February 22, 2024Applicant: West Affum Holdings DACInventor: Jaeho Kim